Biomarker for migraine; posterior cortical atrophy gene therapy for neuromuscular disorders

Neurology Today in 5
12/02/2024 4 min Temporada 24 Episodio 4
Biomarker for migraine; posterior cortical atrophy gene therapy for neuromuscular disorders

Listen "Biomarker for migraine; posterior cortical atrophy gene therapy for neuromuscular disorders"

Descargar episodio Ver en sitio original

Episode Synopsis

Neurology Today Editor-in-chief Joseph E. Safdieh, MD, FAAN, discusses a new study showing retinal vascular perfusion as a migraine biomarker, clinical and pathophysiological correlates of posterior cortical atrophy, and advances in gene therapies for neuromuscular disorders.

More episodes of the podcast Neurology Today in 5

50 years of monoclonal antibodies, pregabalin and heart failure, combined therapy for primary progressive aphasia 06/11/2025
Novel PET radiotracer, GLP-1s and dementia risk, green space benefits 16/10/2025
Pegivirus' role in Parkinson's disease, GLP-1s and idiopathic intracranial hypertension, geographic spread of epilepsy specialists 02/10/2025
Food deserts and stroke risk, physical activity in Parkinson's disease, rimegepant for migraine 18/09/2025
Parkinson's and dementia with Lewy bodies blood test, CAR T-cell therapy for glioblastoma, wireless EEG 04/09/2025
Small fiber neuropathy, Dr. Merit Cudkowicz, work-life balance for families of neurologists 21/08/2025
Divisive treatment for cluster headache, head positioning before thrombectomy, new series, "Neurology in America" 07/08/2025
New treatment for giant-cell arteritis, links between oral and brain health, an emerging meningitis B vaccine 17/07/2025
Telomere length and and risk for neurologic disorders, impact of research cuts on promotion/tenure, herpes zoster vaccine and dementia 03/07/2025
Post-TIA fatigue, neurologic complications of measles, CDC surveillance of epilepsy program dismantled. 19/06/2025
© 2003-2025 ZARZA | AHEAD OF OUR TIME
privacy policy
In God we trust In God we trust
PreSales Questions? Click Here
or call our toll-free line at +1-888-5002068 Miami, Florida, USA